Last reviewed · How we verify

NCT04202718

VitalConnect VitalPatch ECG Interpretation/Arrhythmia Detection

Withdrawn NA Last updated 24 June 2020
What this trial tests

NA trial testing VitalPatch Device in Arrythmia, Cardiac. Withdrawn.

Timeline
15 May 2020
Primary endpoint
30 November 2020
30 November 2020

Quick facts

Lead sponsorMercy Research
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Start date15 May 2020
Primary completion30 November 2020
Estimated completion30 November 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mercy Research — full company profile →

Who can join

18 and older, any sex, with Arrythmia, Cardiac. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Subjects in this study will wear the VitalPatch with the added ECG Interpretation and arrhythmia detection features which will expedite the identification of patients whose condition may rapidly deteriorate as well as eliminate the majority of non-actionable alarms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Arrythmia, Cardiac

Currently open trials in the same condition.

Other Mercy Research trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04202718.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing